Ms Veronica Moroz

Institute of Cancer and Genomic Sciences
Senior Biostatistician

Contact details

Address
Institute of Cancer and Genomic Sciences
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Veronica is a Senior Biostatistician at the Cancer Research UK Clinical Trials Unit (CRCTU). She obtained an MSc in Medical Statistics from the University of Leicester. She works predominantly on paediatric cancer clinical trials and is responsible for the design and analysis of several clinical trials within the CRCTU. Her research interest is in phase II / III clinical trial methodology for rare populations. Veronica is working on several international clinical trials in neuroblastoma, Ewing’s sarcoma and is a co-investigator on clinical trials in hepatoblastoma and rhabdomyosarcoma. She has previously worked on trials in Wilms cancer, myeloma, Crohn's disease, personality disorder and stroke. Veronica has several scientific advisory roles, one of which is an independent statistician on data monitoring committees, and another is statistical reviewer for a clinical journal. 

Qualifications

  • MSc Medical Statistics, University of Leicester, 2007
  • BSc Mathematics (1st class), Nottingham Trent University, 2006

Biography

Prior to joining University of Birmingham, Veronica worked at clinical trial units at University of Nottingham and University of Leicester. She joined Cancer Research UK Clinical Trials Unit in 2010.

Teaching

Veronica lectures on the Advanced Clinical Trials module of the  MSc Clinical Oncology, teaches on MBChB Medicine and Surgery, Critical Appraisal Skills Programme, and provides training for internal staff within Cancer Research UK Clinical Trials Unit. 

Postgraduate supervision

Veronica has supervised MSc Clinical Oncology dissertations.

Research

Veronica’s main research interest is in efficient clinical trial methodology in particular the challenges that arise when designing and implementing complex international trials in rare diseases such as paediatric cancers. This includes adaptive trial design, seamless phase II / III trials, selection designs and application of Bayesian methods. 

Other activities

  • Independent data monitoring committee member of national clinical trials.
  • Appointed member of National Cancer Research Institute Children’s Cancer and Leukaemia Clinical Studies Group (2017 - present).
  • Appointed member of National Cancer Research Institute Teenage and Young adult & Clinical Studies Group (2017 - 2018).